This Research Topic of Frontiers in Medicine is focused on the new diagnostic and therapeutic protocols in the field of skin (solid tumors and lymphoma) and soft tissue oncology with an emphasis on challenging, complex, and advanced clinical scenarios as follows;
• patients presenting with numerous and or recurring skin and soft tissue malignancies.
• immune deficiencies, including but not limited to organ transplant patients.
• management of patients with adverse events due to underlying oncological treatments such as life-saving clinical trials or treatment protocols.
• describing the cutaneous adverse events of emerging oncological treatment not yet reported in the literature.
• germ-line or tumor mutations that are believed to play a role in the severity or complexity of the phenotype of the skin and soft tissue tumors
• the role of oncoviruses in the development of cutaneous malignancies and using such understating and etiology towards immunization, therapeutic and preventive measures.
This Research Topic in Frontiers in Medicine will also be a platform to present the new and emerging technologies applied to cutaneous and soft tissue oncology, such as:
• radiation therapy
• imaging technologies,
• supervised or non-supervised computed algorithms and AI applied to the skin and soft tissue.
• bio-photonics and optical technology applied to the skin and soft tissue
Additionally, innovative molecular histopathology for diagnostic, risk stratifying, or therapeutic measures in the field of dermatopathology is within the scope of this Research Topic. Moreover, surgical approaches or a combination of surgical and non-surgical protocols with emphasis on the outcome, or the data analysis of surgical outcome that has is more comprehensive and preferably prospective compare to existing information in the literature.
Investigator-initiated clinical trials and commentaries with a point of view towards prevention, early detection, or better risk stratification of patients at higher risk for skin malignancies compare to the general population are also of interest for this Research Topic on cutaneous oncology and skin cancer genomics.
It is with deepest sorrow that we share with you the passing of our co-editor Professor Jouni Uitto, to whom we dedicate this collection.
This Research Topic of Frontiers in Medicine is focused on the new diagnostic and therapeutic protocols in the field of skin (solid tumors and lymphoma) and soft tissue oncology with an emphasis on challenging, complex, and advanced clinical scenarios as follows;
• patients presenting with numerous and or recurring skin and soft tissue malignancies.
• immune deficiencies, including but not limited to organ transplant patients.
• management of patients with adverse events due to underlying oncological treatments such as life-saving clinical trials or treatment protocols.
• describing the cutaneous adverse events of emerging oncological treatment not yet reported in the literature.
• germ-line or tumor mutations that are believed to play a role in the severity or complexity of the phenotype of the skin and soft tissue tumors
• the role of oncoviruses in the development of cutaneous malignancies and using such understating and etiology towards immunization, therapeutic and preventive measures.
This Research Topic in Frontiers in Medicine will also be a platform to present the new and emerging technologies applied to cutaneous and soft tissue oncology, such as:
• radiation therapy
• imaging technologies,
• supervised or non-supervised computed algorithms and AI applied to the skin and soft tissue.
• bio-photonics and optical technology applied to the skin and soft tissue
Additionally, innovative molecular histopathology for diagnostic, risk stratifying, or therapeutic measures in the field of dermatopathology is within the scope of this Research Topic. Moreover, surgical approaches or a combination of surgical and non-surgical protocols with emphasis on the outcome, or the data analysis of surgical outcome that has is more comprehensive and preferably prospective compare to existing information in the literature.
Investigator-initiated clinical trials and commentaries with a point of view towards prevention, early detection, or better risk stratification of patients at higher risk for skin malignancies compare to the general population are also of interest for this Research Topic on cutaneous oncology and skin cancer genomics.
It is with deepest sorrow that we share with you the passing of our co-editor Professor Jouni Uitto, to whom we dedicate this collection.
